TY - JOUR T1 - Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2015.PA4228 VL - 46 IS - suppl 59 SP - PA4228 AU - Eve Denton AU - Matthew Conron AU - David Hart AU - Gavin Wright AU - Rory Wolfe AU - Prue Russell Y1 - 2015/09/01 UR - http://erj.ersjournals.com/content/46/suppl_59/PA4228.abstract N2 - Background: The association between lower socioeconomic status (SES) and lung cancer has been established internationally but not extensively in Australia.Aims: To describe a large cohort of lung cancer patients, perform survival analysis and examine differences between patients of different SES.Methods: Data was collected on 2369 consecutive lung cancer patients managed by St Vincent's Hospital Lung Multi-disciplinary Meeting (MDM) 2001-14. Postcode data was used to stratify people by SES and geographical remoteness.Results: Mean age at diagnosis was 68 years with 63% males and 37% females. Presentation was incidental in 25%, symptomatic in 75%, and screened in <1%. There was no difference between socioeconomic groups in age, gender or presentation. Overall 88.5% were smokers and 11.5% never smokers. There were significantly increased smoking rates (92% Vs 83%, p=0.001) and a trend towards less adenocarcinoma with lower SES. Treatment was of curative intent in 54% and palliative in 46%. There was surprisingly earlier stage disease, more curative treatment and lower overall mortality in lower SES patients explained by referral patterns. Survival analysis revealed a 5-year survival of 30% overall, 32% for NSCLC and 8.7% SCLC, and an unexpected improvement in overall survival with lower SES that was not present after adjustment for stage.Conclusion: Overall and stage-stratified survival was above average and stage-stratified survivial did not differ between different socioeconomic groups supporting referral to lung cancer MDMs based in high throughput centres. ER -